Objective: To assess the efficacy, safety and tolerability of moxifloxacin, an 8-methoxy fluoroquinolone, in patients with respiratory tract infections (RTIs) treated in general practice in Germany.

Objective: To assess the efficacy, safety and tolerability of oral moxifloxacin in outpatients with respiratory tract infections treated in general practices in Germany with the focus on community ...

The HCL journey has been relentless, gratifying and marked with a series of achievements. Our unified efforts have catapulted the company from a garage start-up to a conglomerate whose businesses span ...

Bonus Dec 05, 2019 Dec 07, 2019 Oct 23, 2019 Bonus Ratio: 1 share(s) for every 1 shares held Bonus Mar 19, 2015 Mar 20, 2015 Jan 30, 2015 Bonus Ratio: 1 share(s) for every 1 shares held Bonus Mar 15, ...

He had accepted laparoscopic cholecystectomy in other hospitals. Meanwhile, he is allergic to moxifloxacin hydrochloride. After decades of smoking and drinking, he has quit smoking and drinking for 5 ...

You also acknowledge and agree that your employment with HCL is subject to your receiving a clean background verification report. HCL reserves the right to revoke your offer and/or terminate your ...

IT major HCL Technologies has given a salary hike of 7 per cent to its employees. The pay increment, which will be effective October 2024, for top performers is up to 12-15 per cent, Chief People ...

Bonus May 05, 1995 Jun 01, 1995 Feb 16, 1995 Bonus Ratio: 1 share(s) for every 2 shares held Rights Aug 07, 1992 Sep 01, 1992 Sep 30, 1992 Rights ratio: 1 share for every 1 held at a price of Rs 60.0 ...

We are HCLTech Ltd, its subsidiaries and affiliated entities (hereinafter “HCLTech”, "We" or "Us"). HCLTech is the Data Controller of your personal data as ...

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.